[Federal Register Volume 89, Number 207 (Friday, October 25, 2024)]
[Notices]
[Page 85216]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-24925]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Meeting of the Lead Exposure and Prevention Advisory Committee

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, the 
Centers for Disease Control and Prevention announces the following 
meeting for the Lead Exposure and Prevention Advisory Committee 
(LEPAC). This virtual meeting is open to the public. Advance 
registration by December 4, 2024, is needed to receive the information 
to join the meeting. The registration link is provided in the addresses 
section below.

DATES: The meeting will be held on December 11, 2024 from 11 a.m. to 5 
p.m., EST.

ADDRESSES: Register in advance https://events.gcc.teams.microsoft.com/event/0e538aa3-bc82-43e9-89ee-d997b498cfe6@9ce70869-60db-44fd-abe8-d2767077fc8f to receive information to join the meeting.

FOR FURTHER INFORMATION CONTACT: Paul Allwood, Ph.D., M.P.H., 
Designated Federal Officer, National Center for Environmental Health, 
Centers for Disease Control and Prevention, 4770 Buford Highway, 
Atlanta, Georgia 30341, Telephone: 770-488-6774; Email: <a href="/cdn-cgi/l/email-protection#4e020b1e0f0d0e2d2a2d60292138"><span class="__cf_email__" data-cfemail="a2eee7f2e3e1e2c1c6c18cc5cdd4">[email protected]</span></a>.

SUPPLEMENTARY INFORMATION: 
    Background: The Lead Exposure and Prevention Advisory Committee was 
established under Section 2203 of Public Law 114-322, the Water 
Infrastructure Improvements for the Nation Act; 42 U.S.C. 300j-21, 
Registry for Lead Exposure and Prevention Advisory Committee.
    Purpose: The LEPAC is charged with providing advice and guidance to 
the Secretary, Department of Health and Human Services (HHS), and the 
Director, CDC and Administrator, ATSDR, on (1) reviewing Federal 
programs and services available to individual communities exposed to 
lead; (2) reviewing current research on lead exposure to identify 
additional research needs; (3) reviewing and identifying best 
practices, or the need for best practices regarding lead screening and 
the prevention of lead poisoning; (4) identifying effective services, 
including services relating to healthcare, education, and nutrition for 
individuals and communities affected by lead exposure and lead 
poisoning, including in consultation with, as appropriate, the lead 
exposure registry as established in Section 2203(b) of Public Law 114-
322; and (5) undertaking any other review or activities that the 
Secretary determines to be appropriate.
    Matters to be Considered: The agenda will include presentations and 
discussions on the following topics: vote on the 2023 annual LEPAC 
report, report from the Preventing Lead Exposure in Adults workgroup, 
lead related updates from the LEPAC members, local perspective on 
improving blood lead testing, blood lead testing strategies. Agenda 
items are subject to change as priorities dictate.

Public Participation

    Oral Public Comment: The public comment period is scheduled on 
December 11, 2024, from 12:30 p.m. until 12:50 p.m., EST. Individuals 
wishing to make a comment during the public comment period, please 
email your name, organization, and phone number by November 25, 2024, 
to <a href="/cdn-cgi/l/email-protection#a7ebe2f7e6e4e7c4c3c489c0c8d1"><span class="__cf_email__" data-cfemail="58141d08191b183b3c3b763f372e">[email protected]</span></a>.
    The Director, Office of Strategic Business Initiatives, Office of 
the Chief Operating Officer, Centers for Disease Control and 
Prevention, has been delegated the authority to sign Federal Register 
notices pertaining to announcements of meetings and other committee 
management activities, for both the Centers for Disease Control and 
Prevention and the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Office of Strategic Business Initiatives, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2024-24925 Filed 10-24-24; 8:45 am]
BILLING CODE 4163-18-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>